Stryker (LTS:0R2S) Research & Development: $1,631 Mil (TTM As of Mar. 2026)


LTS:0R2S Stryker Corp LTS:0R2S
93 GF Score
Price $330.34
GF Value $408.10
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Stryker Research & Development?

Stryker LTS:0R2S +3.92% 93 Research & Development is $1,631 Mil as of Mar. 2026. GuruFocus rates LTS:0R2S with a GF Score™ of 93/100 and a GF Value™ of $408.10 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Stryker's Research & Development for the three months ended in Mar. 2026 was $413 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $1,631 Mil.

Stryker  (LTS:0R2S) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Stryker Research & Development Related Terms

Stryker Research & Development Historical Data

* Premium members only.

The historical data trend for Stryker's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker Research & Development Chart

Stryker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,235.00 1,454.00 1,388.00 1,466.00 1,623.00

Stryker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 405.00 407.00 410.00 401.00 413.00
LTS:0R2S
93GF Score
Stryker Corp LTS:0R2S
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stryker Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,631 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1,631 Mil mean?
Stryker (LTS:0R2S) has a Research & Development of $1,631 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Stryker and its competitors.
Is Stryker's Research & Development too high?
Stryker's current Research & Development is $1,631 Mil. Overall, Stryker has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stryker's Research & Development compare to MDT and ABT?
Stryker's Research & Development of $1,631 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Stryker and its competitors. Stryker's current Research & Development is $1,631 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stryker stock overvalued right now?
Based on GuruFocus' analysis, Stryker (LTS:0R2S) is currently considered Modestly Undervalued. The stock's GF Value™ is $408.10, compared to a current price of $330.34 — trading 19.1% below its estimated fair value. The current Research & Development is $1,631 Mil. Stryker's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Stryker (LTS:0R2S), the current Research & Development is $1,631 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stryker (LTS:0R2S) Overvalued in 2026?

Based on GuruFocus' analysis, Stryker stock appears to be undervalued. The current stock price of $330.34 is trading 19.1% below its estimated GF Value™ of $408.10. GuruFocus considers Stryker to be Modestly Undervalued.

Key valuation signals for LTS:0R2S:

  • Research & Development: $1,631 Mil
  • GF Value™: $408.10 vs. price of $330.34 (19.1% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the LTS:0R2S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stryker Business Description

Address 1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
93GF Score

Get the complete analysis for LTS:0R2S

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$330.34
Price
$408.10
GF Value